Program Description
In 2024, several innovative specialty medications have been approved, each with unique clinical indications and therapeutic potential. Pharmacists, as integral members of the health care team, must stay informed about these new approvals to provide optimal patient care. This activity will review select new specialty medications approved by the United States Food and Drug Administration in 2024. Understanding the indications along with key characteristics of these medications, including their dosing regimens, administration methods, and safety profiles, is crucial for pharmacists to recommend appropriate therapies and ensure patients receive the most effective treatments. Through this activity, pharmacists will gain valuable insights into the latest advancements in select recently approved specialty drugs, enhancing their ability to contribute to patient care and improve health outcomes.
Target Audience: Pharmacists and pharmacy technicians
Type of Activity: Knowledge
Release date: February 6, 2025
Expiration date: February 6, 2026
Learner level: Foundational
Time to complete activity: 2.0 hours
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
- Discuss the clinical indications of select new specialty medications approved by the US Food and Drug Administration in 2024
- Review the key characteristics of these medications, including dosing, administration, and safety profiles to properly assess, counsel, and monitor patients on therapy
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
